Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC Patients

Clinical trial NCT05375994 · COMPLETED

Trial details

NCT number: NCT05375994
Sponsor: Verastem, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer KRAS Activating Mutation Advanced Cancer Metastatic Cancer Malignant Neoplasm of Lung Malignant Neoplastic Disease

Start date: 2022-08-01
Primary completion: 2026-06-15
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.